CCK-8 assay showed that the overexpressed SLC6A1 distinctly promoted the cell proliferation of prostate cancer cell lines (for PC3 and LNCaP cells: both P < 0.05, Fig. 2b). Here, SLC6A1 is linked to prostate carcinoma.